| http://www.w3.org/ns/prov#value | - lism, especially dyslipidemias, as well as reducing the global cardiovascular risk.More generally, by acting simultaneously on several regulation processes, the compounds according to the invention are an advantageous therapeutic means for the treatment of complications associated with metabolic syndrome (the features of which are obesity, in particular abdominal obesity, an abnormal concentration
|
